Understanding coping strategies in children with cancer and their parents
Coping and Attachment in Pediatric Oncohematology: Multicenter Cross-sectional Study to Assess Emotional Resources and Attachment Dynamics Related to Coping Strategies in Parents of Children With Oncohematologic Disease
This study looks at how children with cancer and their parents handle the illness together to see what helps them cope better during treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 8 Years to 17 Years |
| Sex | All |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 3 sites (Monza, Monza-Brianza and 2 other locations) |
| Trial ID | NCT06858163 on ClinicalTrials.gov |
What this trial studies
This observational study examines how pediatric cancer patients cope with their illness and how this is influenced by their relationships with their parents. It focuses on the interaction between parental coping strategies and child coping behaviors, aiming to identify the factors that contribute to effective coping in the context of pediatric oncology. The study will involve parents and children aged 8 to 17 who are currently undergoing treatment in specific pediatric oncohematology departments. By analyzing these dynamics, the research seeks to provide insights into improving support for families dealing with pediatric cancer.
Who should consider this trial
Good fit: Ideal candidates include children aged 8 to 17 undergoing treatment for cancer and their parents who are fluent in Italian.
Not a fit: Patients who are off-therapy or do not have a parent participating in the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this study could enhance coping strategies for both children and parents, leading to better psychological outcomes during cancer treatment.
How similar studies have performed: Previous studies in oncology have shown that understanding coping strategies can significantly impact patient and family outcomes, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Parents Inclusion Criteria: * parents of both sexes * age of son/daughter between 8 and 17 years old (included) * son/daughter being treated at the Pediatric Oncohematology departments involved in the research (Day Hospital and hospitalization) * good understanding of the Italian language Parents Exclusion Criteria: ● son/daughter in off-therapy Patients Inclusion Criteria: * age between 8 and 17 years old (included), undergoing treatment at the Pediatric Oncohematology departments (Day Hospital and hospitalization) * parents enrolled in the study * good understanding of the Italian language Patients Exclusion Criteria: ● patients in off-therapy
Where this trial is running
Monza, Monza-Brianza and 2 other locations
- Ospedale San Gerardo, SC Ematologia Pediatrica — Monza, Monza-Brianza, Italy (Recruiting)
- SC Ematologia 2 - Oncoematologia pediatrica — Pavia, Pavia, Italy (Recruiting)
- Struttura Complessa di Pediatria e Oncoematologia Pediatrica, Ospedale SS Annunziata — Taranto, Taranto, Italy (Recruiting)
Study contacts
- Study coordinator: Marco Zecca, MD
- Email: m.zecca@smatteo.pv.it
- Phone: +390382501258
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.